Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 20
2004 16
2005 29
2006 44
2007 44
2008 49
2009 69
2010 84
2011 97
2012 96
2013 125
2014 136
2015 168
2016 173
2017 188
2018 199
2019 252
2020 326
2021 377
2022 397
2023 333
2024 141

Text availability

Article attribute

Article type

Publication date

Search Results

3,034 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: zhao j. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization.
Song Q, Datta S, Liang X, Xu X, Pavicic P, Zhang X, Zhao Y, Liu S, Zhao J, Xu Y, Xu J, Wu L, Wu Z, Zhang M, Zhao Z, Lin C, Wang Y, Han P, Jiang P, Qin Y, Li W, Zhang Y, Luo Y, Sen G, Stark GR, Zhao C, Hamilton T, Yang J. Song Q, et al. Among authors: zhao j. Cell Mol Immunol. 2023 Feb;20(2):143-157. doi: 10.1038/s41423-022-00966-y. Epub 2023 Jan 4. Cell Mol Immunol. 2023. PMID: 36596875 Free PMC article.
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Mazieres J, Paik PK, Garassino MC, Le X, Sakai H, Veillon R, Smit EF, Cortot AB, Raskin J, Viteri S, Wu YL, Yang JCH, Ahn MJ, Ma R, Zhao J, O'Brate A, Berghoff K, Bruns R, Otto G, Johne A, Felip E, Thomas M. Mazieres J, et al. Among authors: zhao j. JAMA Oncol. 2023 Sep 1;9(9):1260-1266. doi: 10.1001/jamaoncol.2023.1962. JAMA Oncol. 2023. PMID: 37270698 Free PMC article. Clinical Trial.
The role of cannabidiol in aging.
Ni B, Liu Y, Dai M, Zhao J, Liang Y, Yang X, Han B, Jiang M. Ni B, et al. Among authors: zhao j. Biomed Pharmacother. 2023 Sep;165:115074. doi: 10.1016/j.biopha.2023.115074. Epub 2023 Jul 6. Biomed Pharmacother. 2023. PMID: 37418976 Free article. Review.
Early detection of visual impairment in young children using a smartphone-based deep learning system.
Chen W, Li R, Yu Q, Xu A, Feng Y, Wang R, Zhao L, Lin Z, Yang Y, Lin D, Wu X, Chen J, Liu Z, Wu Y, Dang K, Qiu K, Wang Z, Zhou Z, Liu D, Wu Q, Li M, Xiang Y, Li X, Lin Z, Zeng D, Huang Y, Mo S, Huang X, Sun S, Hu J, Zhao J, Wei M, Hu S, Chen L, Dai B, Yang H, Huang D, Lin X, Liang L, Ding X, Yang Y, Wu P, Zheng F, Stanojcic N, Li JO, Cheung CY, Long E, Chen C, Zhu Y, Yu-Wai-Man P, Wang R, Zheng WS, Ding X, Lin H. Chen W, et al. Among authors: zhao j. Nat Med. 2023 Feb;29(2):493-503. doi: 10.1038/s41591-022-02180-9. Epub 2023 Jan 26. Nat Med. 2023. PMID: 36702948
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Jin F, Gao H, An G, Ding C, Jiang X, Xiong J, Zhou X, Hu S, Lu P, Liu A, Guo S, Huang J, Zhu C, Zhao J, Gao B, Chen Y, Hu C, Zhang J, Zhang H, Zhao H, Tai Y, Ma X, Shi W; CameL Study Group. Zhou C, et al. Among authors: zhao j. J Thorac Oncol. 2023 May;18(5):628-639. doi: 10.1016/j.jtho.2022.12.017. Epub 2023 Jan 13. J Thorac Oncol. 2023. PMID: 36646210 Clinical Trial.
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.
Liam CK, Ahmad AR, Hsia TC, Zhou J, Kim DW, Soo RA, Cheng Y, Lu S, Shin SW, Yang JC, Zhang Y, Zhao J, Berghoff K, Bruns R, Johne A, Wu YL. Liam CK, et al. Among authors: zhao j. Clin Cancer Res. 2023 May 15;29(10):1879-1886. doi: 10.1158/1078-0432.CCR-22-3318. Clin Cancer Res. 2023. PMID: 36971777 Free PMC article. Clinical Trial.
3,034 results